Jakob Dupont - Net Worth and Insider Trading

Jakob Dupont Net Worth

The estimated net worth of Jakob Dupont is at least $165,516 dollars as of 2024-12-27. Jakob Dupont is the EVP, Head of R&D of Atara Biotherapeutics Inc and owns about 11,632 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $147,145. Jakob Dupont is the SVP & Chief Medical Officer of OncoMed Pharmaceuticals Inc and owns about 20,642 shares of OncoMed Pharmaceuticals Inc (OMED) stock worth over $18,371. Jakob Dupont is also the Chief Medical Officer of Gossamer Bio Inc and owns about 0 shares of Gossamer Bio Inc (GOSS) stock worth over $0. Details can be seen in Jakob Dupont's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jakob Dupont has not made any transactions after 2023-03-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jakob Dupont

To

Jakob Dupont Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jakob Dupont owns 6 companies in total, including Atara Biotherapeutics Inc (ATRA) , Gossamer Bio Inc (GOSS) , and OncoMed Pharmaceuticals Inc (OMED) among others .

Click here to see the complete history of Jakob Dupont’s form 4 insider trades.

Insider Ownership Summary of Jakob Dupont

Ticker Comapny Transaction Date Type of Owner
ATRA Atara Biotherapeutics Inc 2023-03-02 EVP & Head of R&D
GOSS Gossamer Bio Inc 2019-12-30 Chief Medical Officer
OMED OncoMed Pharmaceuticals Inc 2016-10-09 SVP & Chief Medical Officer
LIMIT LIMIT 2022-07-29 director
LIMIT LIMIT 2023-08-23 director
LIMIT LIMIT 2022-07-29 director

Jakob Dupont Latest Holdings Summary

Jakob Dupont currently owns a total of 3 stocks. Among these stocks, Jakob Dupont owns 11,632 shares of Atara Biotherapeutics Inc (ATRA) as of March 2, 2023, with a value of $147,145 and a weighting of 88.9%. Jakob Dupont owns 20,642 shares of OncoMed Pharmaceuticals Inc (OMED) as of January 11, 2016, with a value of $18,371 and a weighting of 11.1%. Jakob Dupont also owns 0 shares of Gossamer Bio Inc (GOSS) as of December 30, 2019, with a value of $0 and a weighting of 0%.

Latest Holdings of Jakob Dupont

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATRA Atara Biotherapeutics Inc 2023-03-02 11,632 12.65 147,145
OMED OncoMed Pharmaceuticals Inc 2016-01-11 20,642 0.89 18,371
GOSS Gossamer Bio Inc 2019-12-30 0 0.85 0

Holding Weightings of Jakob Dupont


Jakob Dupont Form 4 Trading Tracker

According to the SEC Form 4 filings, Jakob Dupont has made a total of 11 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Atara Biotherapeutics Inc is the sale of 203 shares on March 2, 2023, which brought Jakob Dupont around $18,419.

According to the SEC Form 4 filings, Jakob Dupont has made a total of 0 transactions in OncoMed Pharmaceuticals Inc (OMED) over the past 5 years. The most-recent trade in OncoMed Pharmaceuticals Inc is the sale of 2,500 shares on January 11, 2016, which brought Jakob Dupont around $50,025.

According to the SEC Form 4 filings, Jakob Dupont has made a total of 1 transactions in Gossamer Bio Inc (GOSS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Gossamer Bio Inc is the sale of 41,994 shares on December 30, 2019, which brought Jakob Dupont around $631,590.

Insider Trading History of Jakob Dupont

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jakob Dupont Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jakob Dupont Ownership Network

Ownership Network List of Jakob Dupont

No Data

Ownership Network Relation of Jakob Dupont

Insider Network Chart

Jakob Dupont Owned Company Details

What does Atara Biotherapeutics Inc do?

Who are the key executives at Atara Biotherapeutics Inc?

Jakob Dupont is the EVP & Head of R&D of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , EVP & Chief Sci. & Tech Officer Anhco Nguyen , and SVP & CFO Eric J Hyllengren .

Atara Biotherapeutics Inc (ATRA) Insider Trades Summary

Over the past 18 months, Jakob Dupont made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 81,112 shares made by Anhco Nguyen , a net sale of 57,905 shares made by Eric J Hyllengren , and a net sale of 38,205 shares made by Jill Henrich .

In summary, during the past 3 months, insiders sold 4,028 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 4,028 shares. During the past 18 months, 28,300 shares of Atara Biotherapeutics Inc (ATRA) were sold and 32,673 shares were bought by its insiders, resulting in a net purchase of 4,373 shares.

Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Atara Biotherapeutics Inc Insider Transactions

No Available Data

Jakob Dupont Mailing Address

Above is the net worth, insider trading, and ownership report for Jakob Dupont. You might contact Jakob Dupont via mailing address: C/o Oncomed Pharmaceuticals, Inc., 800 Chesapeake Drive, Redwood City Ca 94063.

Discussions on Jakob Dupont

No discussions yet.